2026-01-27 - Analysis Report
# Morgan Stanley (MS) Financial Report

## Company Overview
Morgan Stanley is a leading global financial services firm providing a wide range of investment banking, securities, investment management, and other financial services to a diverse group of corporations, governments, financial institutions, and individual investors.

## Return Rate Analysis

- Cumulative return of review stock: **282.16%**
- Cumulative return of comparison stock (S&P 500, VOO): **127.58%**
- Divergence: **149.70**
- Relative divergence: **87.30%**

The review stock has shown a significantly higher cumulative return compared to the S&P 500, indicating a high divergence.

## Alpha, Beta Analysis

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 6.0% | 21.5% | -2.0% | 63.0B |
| 2017-2019  | -14.0% | 21.5% | -39.0% | 81.2B |
| 2018-2020  | 14.0% | 49.7% | -10.0% | 108.9B |
| 2019-2021  | 123.0% | 49.7% | 59.0% | 156.0B |
| 2020-2022  | 55.0% | 49.7% | 51.0% | 135.1B |
| 2021-2023  | 32.0% | 30.4% | 14.0% | 148.2B |
| 2022-2024  | 27.0% | 30.4% | -3.0% | 199.8B |
| 2023-2025  | 148.0% | 28.7% | 73.0% | 282.1B |

The review stock has shown a fluctuating performance over the years, with increasing values in terms of Alpha and Beta.

## Recent Stock Price Fluctuations

- Close: **$181.88**
- Last-market: {'price': 181.88, 'previousClose': 179.0, 'change': 1.61}
- 5-day SMA: **$181.87**
- 20-day SMA: **$183.51**
- 60-day SMA: **$174.23**

## RSI, PPO Index Indicators and Analysis

- Market Risk Indicator (MRI): **0.70** (Medium Investment recommended)
- RSI: **44.17**
- PPO: **-0.57**
- Hybrid Signal: Buy (Cash 0%) - Risk Level: Medium (MRI 0.70)
- Recent relative divergence change: **-12.70** (worsening)
- 7-day Rank change: **-5** (rank down)
- 7-day Dynamic Expected Return change: **9.10** (improving)
- Expected Return (%): **13.40%** (versus S&P 500)

The current market conditions suggest a Medium Investment risk level. The Hybrid Signal is Buy, and the Expected Return is 13.40%.

## Recent News & Significant Events

[2026-01-26] Microsoft Stock Before Q2 Earnings: Buy Now or Wait for Results? - Zacks Investment Research (news.google.com)
[2026-01-26] Why JPM, BAC, and MS Stocks Are Buoyant in Banking’s ‘Next Phase’ - TipRanks (news.google.com)
... 

These recent news and significant events may affect the stock price and performance.

## Analyst Opinions

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): **2.40** (~Buy)
- Opinions: **21**
- Target Price (avg/high/low): **193.00** / **221.00** / **148.00**

## Recent Earnings Analysis

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-29 | 3.73 | 77.67 B$ |
| 2025-04-30 | 3.47 | 70.07 B$ |
| 2025-01-29 | 3.24 | 69.63 B$ |
| 2024-10-30 | 3.32 | 65.58 B$ |
| 2025-10-29 | 3.32 | 65.58 B$ |

The review stock has shown an increase in revenue and EPS over the past quarters.

## Financial Information

No 'Total Revenue' or 'Gross Profit' data available for MS.

## Comprehensive Analysis

- Based on the current market situation and analysis, the review stock has shown a high divergence from the S&P 500.
- The recent stock price fluctuations have been steady, and the 20-day and 60-day SMAs are increasing.
- The Hybrid Signal is Buy, and the Expected Return is 13.40%.
- Analyst opinions are overwhelmingly positive with a consensus of Buy and a high target price.
- The recent earnings analysis shows an increase in revenue and EPS over the past quarters.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.